HD-OPM Archive
Topics › Aging & longevity

Laron syndrome, with lifelong low IGF-1 and mTOR, shows low cancer, diabetes and CVD risk

Louis Nervegna · Jan 01, 2026 · ♥ 7 reactions · 3 comments · original Facebook post
Aging & longevityInsulin resistance & diabetes
AI summary & key facts

Louis reposts an explanation of Laron syndrome, a mutation preventing IGF-1 production, and notes affected people have almost no cancer or diabetes, lower Alzheimer's risk and low CVD risk.

I copied this post from the rapamycin group…

If you are interested in the topics of mTOR and IGF1 and how they relate to longevity, it is worthwhile to learn something about Laron Syndrome. This rare human disease is caused by a genetic mutation that prevents the liver from making IGF1. As a result, people with Laron Syndrome naturally have low IGF1 and mTOR for their entire lives.

Cancer and diabetes are almost unheard of in people with Laron Syndrome, and they have a large reduction in risk for Alzheimer’s.

In particular, they have a low risk for developing CVD:

Paper · Nature · 2024Could a rare mutation that causes dwarfism also slow ageing?nature.com

Even though they live a relatively normal lifespan, there has never been a documented case of a person with Laron Syndrome dying of cancer (the one case mentioned in this article has been disputed). Their low IGF1 and mTOR appears to make them almost completely immune to terminal cancer.

#laronHD #igf1HD #mtorHD #cancerHD #diabetesHD #alzheimersHD #cvdHD

NBC NewsLittle People of Ecuador Could Hold Key to Cancer CureThey have Laron Syndrome, a form of dwarfism that protects them from cancer and diabetes.nbcnews.com

Research cited

← newer: Willett shares concern that whey powders may raise long-termolder: GLP-1 drugs barely bend the obesity curve, Fontana argues, b →